McMillan Office’s Labcorp LH Stock Holding History

McMillan Office’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68K	Hold	6	–	–	﹤0.01%	465
2026 Q1	$1.6K	Hold	6	–	–	﹤0.01%	462
2025 Q4	$1.5K	Buy	+6	New	+$1.59K	﹤0.01%	456

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McMillan Office's LH Position: Q2 2026 in Review

McMillan Office held its Labcorp (LH) position steady in Q2 2026 at 6 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

McMillan Office first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 847 funds tracked by Wall St. Rank hold LH as of Q2 2026.

McMillan Office held 6 shares of Labcorp worth $1.68K as of Q2 2026.
McMillan Office left its Labcorp share count unchanged in Q2 2026.
Labcorp made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #465 holding.
McMillan Office first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
847 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.